Skip to main content
Clinical Trials/NCT04219059
NCT04219059CompletedNot Applicable

MR Radiomic Features in Prostate Cancer

IRCCS San Raffaele1 site in 1 country200 target enrollmentStarted: September 3, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
200
Locations
1
Primary Endpoint
Number of surrogate bioimaging markers of histological characteristics in MR images

Study Overview

Brief Summary

A combination of correct interpretation of imaging and biopsy has given promising results in terms of detecting clinically significant cancer at radical prostatectomy.

Detailed Description

Quantitative approaches to medical image analysis have been developed in recent years with the aim to overcome the limitation of qualitative image interpretation, and provide biomarkers for disease characterization. In particular, the new paradigm, "radiomics", is emerging as the high-throughput extraction of quantitative features from imaging which can aid in characterizing phenotype as in vivo expression of tumoral genotype. The goal of radiomics is to extract accurate and reliable quantitative biomarkers which enhance diagnostic confidence in oncology. A combination of correct interpretation of imaging and biopsy has given promising results in terms of detecting clinically significant cancer at radical prostatectomy.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • > 18 years of age
  • In house MRI with contrast medium
  • PCa (prostate cancer) biopsy proven diagnosis
  • In house radical prostatectomy

Exclusion Criteria

  • < 18 years of age
  • MRI without contrast medium
  • Radical prostatectomy executed not in Institution

Outcomes

Primary Outcomes

Number of surrogate bioimaging markers of histological characteristics in MR images

Time Frame: 0-2 years

Segment tumor volumes on the ADC map and extract different imaging features

Secondary Outcomes

  • Radiomic features from MRI(0-2 years)
  • Extract radiomic features(0-2 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Francesco De Cobelli

Head, Radiology Department

IRCCS San Raffaele

Study Sites (1)

Loading locations...

Similar Trials